Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
652.00    12.00 (1.88%)
Bid:
644.00
Ask:
660.00
Spread: 16.00 (2.484%)
Market Cap: £219.22m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Trading Update

11 Jul 2012 07:00

Avingtrans Plc ("Avingtrans" or the "Company" or the "Group") Trading Update

Avingtrans (AIM:AVG), a manufacturer of critical components and associatedservices to the medical, energy, industrial and global aerospace sectors ispleased to announce the following pre-close trading update following the end ofits financial year to 31 May 2012. It is expected that the preliminary resultsfor the year then ended will be announced during week commencing 17th September2012.Group sales are expected to be approximately 20% ahead of the previous year, inline with market expectations, with all divisions contributing to this growth.Similarly, operating profit is also expected to be ahead of last year and inline with expectations, reflecting on-going improvements in the Group'sperformance.

Aerospace

The Company is particularly pleased to report improved overall performance inthe Aerospace division. This divisional performance is all the more creditable,given that the Group continues to invest in building the recently formed SigmaComposites business and, while initial sales levels have been lower than hadbeen hoped for, the belief remains that this investment will contributestrongly to the Aerospace division in the future.Looking forward, the Company is pleased to announce that it is in finalnegotiations with the European Union to participate in its "Clean Sky"programme to develop new technology for more environmentally sustainableaircraft, rotorcraft and propulsion systems. Clean Sky is supported by many ofEurope's leading aerospace OEMs. In April 2012, Sigma and its partner TWI, aleading independent research and technology organisation, responded to CleanSky's call to develop non-metallic pipes for aero engines. The contract isvalued at EUR1.7 million.

We are delighted to report that Sigma has been selected as preferred bidder against strong competition. Providing that the final details can be agreed, the Sigma and TWI consortium should receive a contract in August. The programme is expected to last 18 months.

This project fits perfectly with Sigma's technology development roadmap andambition to generate intellectual property. Since the project will lean heavilytowards composite materials, Avingtrans' recent acquisition of Sigma Compositesand TWI's expertise in composites joining and thermoplastics were key factorsin Clean Sky's decision process.

Industrial

Industrial Products has had a solid year with strong results in Germany and theUSA. Recently, Jena Tec's automation division, Moss Group, received ordersworth approximately £600,000. Notable amongst these is a £450,000 order fromNissan Manufacturing UK for the automotive transfer line upgrades for a newengine variant introduction, awarded by Nissan in May 2012 and will comprisethe supply and integration of conveyor systems, fixtures, transfer tables andancillary systems.

This will be integrated in Nissan's Sunderland plant in December 2012, where Jena Tec will provide a complete turnkey retrofit, as Nissan UK expands its production capability for newer engine models.

Energy and Medical

As previously stated at the half year, the performance of the Energy andMedical division has been held back by delays to the next generation MRIsystems being developed by Siemens and, specifically in relation to the Group'sCrown business, on-going market weakness in the transport infrastructuresector. The Siemens programme is however progressing, albeit slower thananticipated and Crown is awaiting final confirmation of a new £200k contractfor CCTV infrastructure on the M4/M5 Managed Motorway programme. In response tomarket weakness, measures have been taken at Crown to manage costs to anabsolute minimum.Beyond the two key factors above, however, the flow of work for the divisionfrom other key customers - eg Cummins - has been satisfactory and new projectwins are in line with forecasts.

Group Outlook

Although market conditions continue to be challenging, buoyed by positive trends in the Aerospace sector, we remain confident overall in continuing to perform in line with market expectations.

Enquiries:Avingtrans plc 0115 949 9020 Steve McQuillan, CEO Stephen King, CFO FinnCap

Marc Young / Henrik Persson - Corporate Finance 020 7600 1658

Brian Patient / Victoria Bates - Corporate Broking

Newgate Threadneedle 020 7653 9850 (Financial PR)

Josh Royston/ Guy McDougall

About Avingtrans

Avingtrans plc is engaged in the provision of highly engineered components

and services to the energy, medical, scientific and research communities, traffic management, automation, machinery and aerospace industries

worldwide.

The business is made up of 3 divisions: • Aerospace, engaged in the manufacture of rigid pipe assemblies and

prismatic components for aero engines and precision polishing of aircraft components;

• Energy and medical, engaged in the manufacture of machined and fabricated

pressure and vacuum vessels and components for the energy, medical, science

and research communities. Design and manufacture of fabricated poles and cabinets for roadside safety cameras and rail track signalling and;

• Industrial products, engaged in the design, manufacture, distribution and

service of precision ballscrews, spindles and related linear and rotary products servicing the original equipment and after markets in global industry. TWI

TWI is one of the world's foremost independent research and technology organisations, with expertise in solving problems in all aspects of manufacturing, fabrication and whole-life integrity management technologies.

Established in Cambridge, in 1946 and with several facilities across the globe,the company has a first class reputation for service through its teams ofinternationally respected consultants, scientists, engineers and support staff,whose knowledge and expertise are available to its Industrial Members as andwhen they require.

XLON
Date   Source Headline
19th May 202610:20 amRNSHolding(s) in Company
14th May 202612:26 pmRNSHolding(s) in Company
12th May 20267:00 amRNSAdaptix receives CE Certification
6th May 20264:28 pmRNSHolding(s) in Company
30th Apr 20262:42 pmRNSHolding(s) in Company
30th Apr 20262:41 pmRNSExercise of Options & TVR
24th Apr 20262:54 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSStrong Nuclear Orders for Avingtrans
26th Mar 20267:00 amRNS-RScientific Magnetics Ships 20th Quantum Magnet
4th Mar 20267:00 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSInterim Results
12th Feb 202611:49 amRNSHolding(s) in Company
6th Feb 202610:24 amRNSHolding(s) in Company
27th Jan 20265:42 pmRNSExercise of Options & TVR
21st Jan 20267:00 amRNSTrading Update and Notice of Results
12th Jan 20265:13 pmRNSIssue of Share Options
12th Jan 20267:00 amRNS-RMedical & Industrial Imaging Division Appointment
8th Dec 20252:34 pmRNSNotification of Major Holdings
27th Nov 20251:59 pmRNSResult of AGM - Board Appointment
14th Nov 20258:38 amRNSExercise of Options & PDMR Dealings
10th Nov 20257:00 amRNSAdaptix receives FDA 510(K) clearance
1st Oct 20254:52 pmRNSExercise of Options & Total Voting Rights
1st Oct 20253:32 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAppointment of Medical Division CEO
24th Sep 20257:00 amRNSPreliminary results for the year ended 31 May 2025
11th Sep 20258:00 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSHayward Tyler Secures $16m Nuclear Contracts
28th Aug 20257:00 amRNSBooth Industries secures £8.5m HS2 & TfL contracts
25th Jun 20257:00 amRNSTrading Update and Notice of Results
28th May 20257:00 amRNSTrading Update
26th Feb 20257:00 amRNSInterim Results
13th Feb 20257:00 amRNSBooth Industries secures £4.5m Contract
16th Jan 20257:00 amRNSTrading Update & Notice of Results
21st Nov 20244:09 pmRNSResult of AGM
24th Oct 20249:07 amRNSHolding(s) in Company
25th Sep 20247:00 amRNSPreliminary results for the year ended 31 May 2024
3rd Jul 20247:00 amRNSPDMR Dealings
19th Jun 20247:00 amRNSTrading Update and Notice of Results
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.